HEADER TRANSFERASE 12-APR-10 3MIY TITLE X-RAY CRYSTAL STRUCTURE OF ITK COMPLEXED WITH SUNITINIB COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE ITK/TSK; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 357-620; COMPND 5 SYNONYM: T-CELL-SPECIFIC KINASE, TYROSINE-PROTEIN KINASE LYK, KINASE COMPND 6 EMT; COMPND 7 EC: 2.7.10.2; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ITK, EMT, LYK; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: SF9 II SFM; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: VIRUS; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PVL KEYWDS HELIX C-IN, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR A.KUGLSTATTER,A.G.VILLASENOR REVDAT 5 06-SEP-23 3MIY 1 REMARK REVDAT 4 06-OCT-21 3MIY 1 COMPND REMARK SEQADV HETNAM REVDAT 3 05-OCT-11 3MIY 1 HETATM VERSN REVDAT 2 18-AUG-10 3MIY 1 JRNL REVDAT 1 30-JUN-10 3MIY 0 JRNL AUTH A.K.KUTACH,A.G.VILLASENOR,D.LAM,C.BELUNIS,C.JANSON,S.LOK, JRNL AUTH 2 L.N.HONG,C.M.LIU,J.DEVAL,T.J.NOVAK,J.W.BARNETT,W.CHU,D.SHAW, JRNL AUTH 3 A.KUGLSTATTER JRNL TITL CRYSTAL STRUCTURES OF IL-2-INDUCIBLE T CELL KINASE COMPLEXED JRNL TITL 2 WITH INHIBITORS: INSIGHTS INTO RATIONAL DRUG DESIGN AND JRNL TITL 3 ACTIVITY REGULATION. JRNL REF CHEM.BIOL.DRUG DES. V. 76 154 2010 JRNL REFN ISSN 1747-0277 JRNL PMID 20545945 JRNL DOI 10.1111/J.1747-0285.2010.00993.X REMARK 2 REMARK 2 RESOLUTION. 1.67 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.67 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 32.02 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 86.1 REMARK 3 NUMBER OF REFLECTIONS : 49551 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.208 REMARK 3 R VALUE (WORKING SET) : 0.207 REMARK 3 FREE R VALUE : 0.234 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2680 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.67 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.69 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1433 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 33.73 REMARK 3 BIN R VALUE (WORKING SET) : 0.2700 REMARK 3 BIN FREE R VALUE SET COUNT : 82 REMARK 3 BIN FREE R VALUE : 0.3340 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3798 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 58 REMARK 3 SOLVENT ATOMS : 307 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 19.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 21.30 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.51000 REMARK 3 B22 (A**2) : -0.77000 REMARK 3 B33 (A**2) : 0.81000 REMARK 3 B12 (A**2) : -0.04000 REMARK 3 B13 (A**2) : -0.33000 REMARK 3 B23 (A**2) : -1.05000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.130 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.120 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.075 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.172 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.949 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.933 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3942 ; 0.006 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5325 ; 0.913 ; 1.971 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 471 ; 4.507 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 178 ;35.087 ;23.820 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 672 ;12.987 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 24 ;15.908 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 574 ; 0.068 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2980 ; 0.002 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1969 ; 0.174 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2705 ; 0.298 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 282 ; 0.091 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 78 ; 0.166 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 22 ; 0.096 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2444 ; 0.446 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3813 ; 0.774 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1730 ; 0.945 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1512 ; 1.543 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3MIY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-APR-10. REMARK 100 THE DEPOSITION ID IS D_1000058602. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL7-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 53980 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.670 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 86.1 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.04700 REMARK 200 FOR THE DATA SET : 15.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.67 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.75 REMARK 200 COMPLETENESS FOR SHELL (%) : 45.8 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.26400 REMARK 200 FOR SHELL : 2.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1SM2 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.04 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.16 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG3350, 0.2M AMMONIUM ACETATE, REMARK 280 0.1M BIS-TRIS, PH 6.0, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 283K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLN A 373 REMARK 465 PHE A 374 REMARK 465 ARG A 394 REMARK 465 GLU A 395 REMARK 465 GLY A 396 REMARK 465 ALA A 397 REMARK 465 MET A 398 REMARK 465 GLY A 502 REMARK 465 MET A 503 REMARK 465 THR A 504 REMARK 465 ARG A 505 REMARK 465 PHE A 506 REMARK 465 VAL A 507 REMARK 465 LEU A 508 REMARK 465 ASP A 509 REMARK 465 ASP A 510 REMARK 465 GLN A 511 REMARK 465 TYR A 512 REMARK 465 THR A 513 REMARK 465 SER A 514 REMARK 465 SER A 515 REMARK 465 THR A 516 REMARK 465 GLY A 517 REMARK 465 THR A 518 REMARK 465 LYS A 519 REMARK 465 PHE A 520 REMARK 465 LEU A 620 REMARK 465 GLN B 373 REMARK 465 PHE B 374 REMARK 465 ARG B 394 REMARK 465 GLU B 395 REMARK 465 GLY B 396 REMARK 465 ALA B 397 REMARK 465 MET B 398 REMARK 465 MET B 503 REMARK 465 THR B 504 REMARK 465 ARG B 505 REMARK 465 PHE B 506 REMARK 465 VAL B 507 REMARK 465 LEU B 508 REMARK 465 ASP B 509 REMARK 465 ASP B 510 REMARK 465 GLN B 511 REMARK 465 TYR B 512 REMARK 465 THR B 513 REMARK 465 SER B 514 REMARK 465 SER B 515 REMARK 465 THR B 516 REMARK 465 GLY B 517 REMARK 465 THR B 518 REMARK 465 LYS B 519 REMARK 465 PHE B 520 REMARK 465 LEU B 620 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 385 -70.70 -128.42 REMARK 500 ARG A 481 -14.93 80.88 REMARK 500 ASP A 482 42.69 -143.31 REMARK 500 ASN A 561 -3.88 60.96 REMARK 500 VAL B 366 -62.02 -95.01 REMARK 500 LYS B 385 -70.03 -135.07 REMARK 500 ARG B 481 -14.33 80.11 REMARK 500 ASP B 482 45.17 -145.37 REMARK 500 ASN B 561 38.92 -99.27 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE B49 A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE B49 B 2 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3MJ2 RELATED DB: PDB REMARK 900 RELATED ID: 3MJ1 RELATED DB: PDB DBREF 3MIY A 357 620 UNP Q08881 ITK_HUMAN 357 620 DBREF 3MIY B 357 620 UNP Q08881 ITK_HUMAN 357 620 SEQADV 3MIY GLY A 355 UNP Q08881 EXPRESSION TAG SEQADV 3MIY SER A 356 UNP Q08881 EXPRESSION TAG SEQADV 3MIY SER A 477 UNP Q08881 CYS 477 ENGINEERED MUTATION SEQADV 3MIY ALA A 614 UNP Q08881 GLU 614 ENGINEERED MUTATION SEQADV 3MIY ALA A 617 UNP Q08881 GLU 617 ENGINEERED MUTATION SEQADV 3MIY GLY B 355 UNP Q08881 EXPRESSION TAG SEQADV 3MIY SER B 356 UNP Q08881 EXPRESSION TAG SEQADV 3MIY SER B 477 UNP Q08881 CYS 477 ENGINEERED MUTATION SEQADV 3MIY ALA B 614 UNP Q08881 GLU 614 ENGINEERED MUTATION SEQADV 3MIY ALA B 617 UNP Q08881 GLU 617 ENGINEERED MUTATION SEQRES 1 A 266 GLY SER VAL ILE ASP PRO SER GLU LEU THR PHE VAL GLN SEQRES 2 A 266 GLU ILE GLY SER GLY GLN PHE GLY LEU VAL HIS LEU GLY SEQRES 3 A 266 TYR TRP LEU ASN LYS ASP LYS VAL ALA ILE LYS THR ILE SEQRES 4 A 266 ARG GLU GLY ALA MET SER GLU GLU ASP PHE ILE GLU GLU SEQRES 5 A 266 ALA GLU VAL MET MET LYS LEU SER HIS PRO LYS LEU VAL SEQRES 6 A 266 GLN LEU TYR GLY VAL CYS LEU GLU GLN ALA PRO ILE CYS SEQRES 7 A 266 LEU VAL PHE GLU PHE MET GLU HIS GLY CYS LEU SER ASP SEQRES 8 A 266 TYR LEU ARG THR GLN ARG GLY LEU PHE ALA ALA GLU THR SEQRES 9 A 266 LEU LEU GLY MET CYS LEU ASP VAL CYS GLU GLY MET ALA SEQRES 10 A 266 TYR LEU GLU GLU ALA SER VAL ILE HIS ARG ASP LEU ALA SEQRES 11 A 266 ALA ARG ASN CYS LEU VAL GLY GLU ASN GLN VAL ILE LYS SEQRES 12 A 266 VAL SER ASP PHE GLY MET THR ARG PHE VAL LEU ASP ASP SEQRES 13 A 266 GLN TYR THR SER SER THR GLY THR LYS PHE PRO VAL LYS SEQRES 14 A 266 TRP ALA SER PRO GLU VAL PHE SER PHE SER ARG TYR SER SEQRES 15 A 266 SER LYS SER ASP VAL TRP SER PHE GLY VAL LEU MET TRP SEQRES 16 A 266 GLU VAL PHE SER GLU GLY LYS ILE PRO TYR GLU ASN ARG SEQRES 17 A 266 SER ASN SER GLU VAL VAL GLU ASP ILE SER THR GLY PHE SEQRES 18 A 266 ARG LEU TYR LYS PRO ARG LEU ALA SER THR HIS VAL TYR SEQRES 19 A 266 GLN ILE MET ASN HIS CYS TRP LYS GLU ARG PRO GLU ASP SEQRES 20 A 266 ARG PRO ALA PHE SER ARG LEU LEU ARG GLN LEU ALA ALA SEQRES 21 A 266 ILE ALA ALA SER GLY LEU SEQRES 1 B 266 GLY SER VAL ILE ASP PRO SER GLU LEU THR PHE VAL GLN SEQRES 2 B 266 GLU ILE GLY SER GLY GLN PHE GLY LEU VAL HIS LEU GLY SEQRES 3 B 266 TYR TRP LEU ASN LYS ASP LYS VAL ALA ILE LYS THR ILE SEQRES 4 B 266 ARG GLU GLY ALA MET SER GLU GLU ASP PHE ILE GLU GLU SEQRES 5 B 266 ALA GLU VAL MET MET LYS LEU SER HIS PRO LYS LEU VAL SEQRES 6 B 266 GLN LEU TYR GLY VAL CYS LEU GLU GLN ALA PRO ILE CYS SEQRES 7 B 266 LEU VAL PHE GLU PHE MET GLU HIS GLY CYS LEU SER ASP SEQRES 8 B 266 TYR LEU ARG THR GLN ARG GLY LEU PHE ALA ALA GLU THR SEQRES 9 B 266 LEU LEU GLY MET CYS LEU ASP VAL CYS GLU GLY MET ALA SEQRES 10 B 266 TYR LEU GLU GLU ALA SER VAL ILE HIS ARG ASP LEU ALA SEQRES 11 B 266 ALA ARG ASN CYS LEU VAL GLY GLU ASN GLN VAL ILE LYS SEQRES 12 B 266 VAL SER ASP PHE GLY MET THR ARG PHE VAL LEU ASP ASP SEQRES 13 B 266 GLN TYR THR SER SER THR GLY THR LYS PHE PRO VAL LYS SEQRES 14 B 266 TRP ALA SER PRO GLU VAL PHE SER PHE SER ARG TYR SER SEQRES 15 B 266 SER LYS SER ASP VAL TRP SER PHE GLY VAL LEU MET TRP SEQRES 16 B 266 GLU VAL PHE SER GLU GLY LYS ILE PRO TYR GLU ASN ARG SEQRES 17 B 266 SER ASN SER GLU VAL VAL GLU ASP ILE SER THR GLY PHE SEQRES 18 B 266 ARG LEU TYR LYS PRO ARG LEU ALA SER THR HIS VAL TYR SEQRES 19 B 266 GLN ILE MET ASN HIS CYS TRP LYS GLU ARG PRO GLU ASP SEQRES 20 B 266 ARG PRO ALA PHE SER ARG LEU LEU ARG GLN LEU ALA ALA SEQRES 21 B 266 ILE ALA ALA SER GLY LEU HET B49 A 1 29 HET B49 B 2 29 HETNAM B49 N-[2-(DIETHYLAMINO)ETHYL]-5-[(Z)-(5-FLUORO-2-OXO-1,2- HETNAM 2 B49 DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]-2,4-DIMETHYL-1H- HETNAM 3 B49 PYRROLE-3-CARBO XAMIDE HETSYN B49 SUNITINIB FORMUL 3 B49 2(C22 H27 F N4 O2) FORMUL 5 HOH *307(H2 O) HELIX 1 1 ASP A 359 SER A 361 5 3 HELIX 2 2 SER A 399 MET A 411 1 13 HELIX 3 3 CYS A 442 GLN A 450 1 9 HELIX 4 4 ALA A 455 ALA A 476 1 22 HELIX 5 5 ALA A 484 ARG A 486 5 3 HELIX 6 6 GLU A 492 GLN A 494 5 3 HELIX 7 7 PRO A 521 ALA A 525 5 5 HELIX 8 8 SER A 526 SER A 533 1 8 HELIX 9 9 SER A 536 SER A 553 1 18 HELIX 10 10 SER A 563 GLY A 574 1 12 HELIX 11 11 SER A 584 TRP A 595 1 12 HELIX 12 12 ARG A 598 ARG A 602 5 5 HELIX 13 13 ALA A 604 GLY A 619 1 16 HELIX 14 14 ASP B 359 SER B 361 5 3 HELIX 15 15 SER B 399 MET B 411 1 13 HELIX 16 16 CYS B 442 GLN B 450 1 9 HELIX 17 17 ALA B 455 ALA B 476 1 22 HELIX 18 18 ALA B 484 ARG B 486 5 3 HELIX 19 19 GLU B 492 GLN B 494 5 3 HELIX 20 20 PRO B 521 ALA B 525 5 5 HELIX 21 21 SER B 526 SER B 533 1 8 HELIX 22 22 SER B 536 SER B 553 1 18 HELIX 23 23 SER B 563 THR B 573 1 11 HELIX 24 24 SER B 584 TRP B 595 1 12 HELIX 25 25 ARG B 598 ARG B 602 5 5 HELIX 26 26 ALA B 604 GLY B 619 1 16 SHEET 1 A 5 LEU A 363 GLY A 370 0 SHEET 2 A 5 LEU A 376 TRP A 382 -1 O LEU A 379 N GLN A 367 SHEET 3 A 5 ASP A 386 THR A 392 -1 O ILE A 390 N HIS A 378 SHEET 4 A 5 CYS A 432 GLU A 436 -1 O LEU A 433 N LYS A 391 SHEET 5 A 5 LEU A 421 CYS A 425 -1 N TYR A 422 O VAL A 434 SHEET 1 B 2 CYS A 488 VAL A 490 0 SHEET 2 B 2 ILE A 496 VAL A 498 -1 O LYS A 497 N LEU A 489 SHEET 1 C 5 LEU B 363 GLY B 370 0 SHEET 2 C 5 LEU B 376 TRP B 382 -1 O LEU B 379 N GLN B 367 SHEET 3 C 5 ASP B 386 THR B 392 -1 O ILE B 390 N HIS B 378 SHEET 4 C 5 CYS B 432 GLU B 436 -1 O PHE B 435 N ALA B 389 SHEET 5 C 5 LEU B 421 CYS B 425 -1 N TYR B 422 O VAL B 434 SHEET 1 D 2 CYS B 488 VAL B 490 0 SHEET 2 D 2 ILE B 496 VAL B 498 -1 O LYS B 497 N LEU B 489 CISPEP 1 ALA A 429 PRO A 430 0 -1.82 CISPEP 2 ALA B 429 PRO B 430 0 -1.38 SITE 1 AC1 14 HOH A 130 ILE A 369 ALA A 389 LYS A 391 SITE 2 AC1 14 PHE A 435 GLU A 436 PHE A 437 MET A 438 SITE 3 AC1 14 GLU A 439 HIS A 440 GLY A 441 LEU A 489 SITE 4 AC1 14 SER A 499 HOH A1092 SITE 1 AC2 12 HOH B 82 ILE B 369 ALA B 389 LYS B 391 SITE 2 AC2 12 PHE B 435 GLU B 436 PHE B 437 MET B 438 SITE 3 AC2 12 GLU B 439 GLY B 441 LEU B 489 HOH B1001 CRYST1 39.479 52.053 66.106 98.49 103.65 92.84 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.025330 0.001257 0.006444 0.00000 SCALE2 0.000000 0.019235 0.003201 0.00000 SCALE3 0.000000 0.000000 0.015781 0.00000